We could have an alternative system where VC don’t need to appease regulators but must place X billion in escrow for compensation of any harm the medicine does to customers.
Regulator is not only there to protect the public, it also protects VC from responsibility
This is why FDA requires experiments before company sells any drugs.
> VC don’t need to appease regulators
Regulations around clinical trials represent the floor of what's ethically permissible, not the ceiling. As in, these guidelines represent the absolute bare minimum required when performing drug trials to prevent gross ethical violations. Not sure what corners you think are ripe for cutting there.